Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$882K Buy
52,395
+420
+0.8% +$7.63K 0.06% 319
2022
Q1
$1.04M Sell
51,975
-6,045
-10% -$124K 0.06% 293
2021
Q4
$1.18M Buy
58,020
+500
+0.9% +$9.95K 0.07% 259
2021
Q3
$1.09M Buy
57,520
+2,915
+5% +$53.6K 0.07% 260
2021
Q2
$924K Buy
54,605
+1,005
+2% +$17.1K 0.06% 306
2021
Q1
$909K Buy
53,600
+5,005
+10% +$85.6K 0.07% 295
2020
Q4
$752K Sell
48,595
-10,585
-18% -$149K 0.06% 324
2020
Q3
$741K Buy
+59,180
New +$728K 0.06% 288
2020
Q1
Sell
-12,225
Closed -$206K 663
2019
Q4
$206K Buy
+12,225
New +$196K 0.02% 596

Other funds holding IX

Advisor Partners's IX Position: Q2 2022 in Review

Advisor Partners increased its ORIX (IX) stake by 0.81% in Q2 2022, buying an estimated $7.63K and bringing the position to 52,395 shares worth $882K. The position accounts for 0.06% of the portfolio, ranked #319.

Advisor Partners first reported a position in IX in Q4 2019 and has held it in 9 quarters since. The position peaked at $1.18M in Q4 2021. 139 funds tracked by Wall St. Rank hold IX as of Q2 2022.

  • Advisor Partners held 52,395 shares of ORIX worth $882K as of Q2 2022.
  • Advisor Partners bought 420 ORIX shares in Q2 2022, an estimated $7.63K.
  • ORIX made up 0.06% of Advisor Partners's portfolio in Q2 2022, its #319 holding.
  • Advisor Partners first reported a position in ORIX in Q4 2019 and has held it in 9 quarters since.
  • Advisor Partners's ORIX position peaked at $1.18M in Q4 2021.
  • 139 funds tracked by Wall St. Rank held ORIX as of Q2 2022.

Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.